MDSpire - Summary
Feature

Farid Takes Helm of Aurion MAB

Aurion Biotech names Marjan Farid chair of medical advisory board

  • March 27, 2026

  • 2 min

Share

Marjan Farid, a renowned cornea and cataract surgeon, has been appointed chair of the medical advisory board at Aurion Biotech, a pioneer in vision restoration therapies. As the Director of Cornea and Refractive Surgery at the Gavin Herbert Eye Institute, Farid will steer the company's clinical strategies, especially in advancing regenerative therapies for corneal diseases, including the Phase 3 therapy AURN001. This initiative aims to tackle the global issue of vision loss caused by corneal endothelial disease.

Original Source(s)

Farid Takes Helm of Aurion MAB

  • March 27, 2026

Related Content

Why Proactive Dry Eye Care Should Be the New Standard

The dental profession long ago decided it was important to preach preventative maintenance for everyone. We should do the same

Busy Isn’t Predictable: The Hidden Risk in High-Performing Eye Clinics

You can look busy on paper and still run a fragile business. Predictable growth only happens when metrics, positioning, and execution are aligned

Layer-Specific Corneal Changes in TED

TVST study identifies diffuse stromal thinning in patients with thyroid eye disease

  • March 25, 2026

  • 3 min